WTO/TRIPs, Pharmaceuticals and Health: Impacts and strategies

Zafar Mirza
Additional contact information
Zafar Mirza: Islamabad, Pakistan

Development, 1999, vol. 42, issue 4, 92-97

Abstract: Zafar Mirza looks at the problems of high drug prices, low access to medicines and the weakening of the national pharmaceutical industry for the majority of the world's population when the ‘Agreement on Trade-Related Aspects of Intellectual Property Rights’ (TRIPs) is to be implemented. Development (1999) 42, 92–97. doi:10.1057/palgrave.development.1110093

Date: 1999
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.palgrave-journals.com/development/journal/v42/n4/pdf/1110093a.pdf Link to full text PDF (application/pdf)
http://www.palgrave-journals.com/development/journal/v42/n4/full/1110093a.html Link to full text HTML (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:develp:v:42:y:1999:i:4:p:92-97

Ordering information: This journal article can be ordered from
http://www.springer. ... es/journal/41301/PS2

Access Statistics for this article

Development is currently edited by Stefano Prato

More articles in Development from Palgrave Macmillan, Society for International Deveopment Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().